Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + R-DHAP in R/R DLBCL
NCT03579082Phase 4Unknown
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of decitabine in diffuse large B-cell lymphoma (DLBCL). Status: unknown.
02
Drugs
decitabine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03579082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03579082.